Free Trial
LON:OVB

Ovoca Bio (OVB) Share Price, News & Analysis

GBX 1.29 +0.04 (+2.96%)
As of 09:51 AM Eastern

About Ovoca Bio Stock (LON:OVB)

Key Stats

Today's Range
1.25
1.29
50-Day Range
1.14
1.48
52-Week Range
0.65
1.98
Volume
311,544 shs
Average Volume
85,750 shs
Market Capitalization
£1.30 million
P/E Ratio
N/A
Dividend Yield
0.83%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Ovoca Bio is a clinical-stage biopharmaceutical company focused on women’s health. Founded and incorporated in Ireland, the business currently operates in Ireland, the UK and Russia. Ovoca Bio is currently developing BP-101, a novel medicinal treatment for premenopausal women suffering from hypoactive sexual desire disorder (HSDD), a condition characterized by a distressing lack or loss of sexual desire affecting an estimated ~4 million women in the US with similar prevalence in other countries globally. The condition represents a significant area of high unmet medical need with few and challenging treatment options.

Receive OVB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ovoca Bio and its competitors with MarketBeat's FREE daily newsletter.

OVB Stock News Headlines

Ovoca Bio plc (OVB.L)
Trump Treasure April 19
Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly that, just 12 months later…
OVB.I - Ovoca Bio PLC Profile | Reuters
See More Headlines

OVB Stock Analysis - Frequently Asked Questions

Ovoca Bio's stock was trading at GBX 1.60 at the beginning of 2025. Since then, OVB shares have decreased by 19.6% and is now trading at GBX 1.29.
View the best growth stocks for 2025 here
.

Shares of OVB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Ovoca Bio investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and J D Wetherspoon (JDW).

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
LON:OVB
CIK
N/A
Fax
N/A
Employees
5
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
£-1,348,918.41
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Cash Flow
GBX 1.28 per share
Price / Cash Flow
1.00
Book Value
GBX 2.41 per share
Price / Book
0.53

Miscellaneous

Free Float
N/A
Market Cap
£1.28 million
Optionable
Not Optionable
Beta
0.90
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

This page (LON:OVB) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners